TORONTO, Aug. 09, 2018 (GLOBE NEWSWIRE) — The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (US:TGODF) announced today that it has selected Shopify Inc. (“Shopify”) (NYSE:SHOP) (TSX:SHOP) to build an innovative ecommerce platform for the delivery of medical and future adult-use organic cannabis world-wide.
The Green Organic Dutchman Holdings Ltd. (TGOD) is a research & development company licensed under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) to cultivate medical cannabis in Canada. TGOD is developing large scale production, global distribution channels and a premium brand to become the leading supplier of organic cannabis worldwide. TGOD is committed to building a powerful, scalable ecommerce solution, and is proud to implement Shopify’s innovative ecommerce platform.
Shopify is the leading cloud-based multichannel ecommerce platform. The company was involved in the partnership between TGOD and Epican Medicinals in Jamaica where they supplied the retail point-of-sale system for Epican’s retail outlets. Additionally, Shopify is developing the pre-registration system for medical patients throughout Jamaica. TGOD will leverage this expertise as it plans for the sale of organic cannabis in domestic and international markets.
We are pleased to announce this agreement with ecommerce giant Shopify. We see tremendous value in this relationship and Shopify will play an instrumental role in our ability to rapidly scale and provide our premium organic cannabis to global markets.
Csaba Reider, President of TGOD
“We look forward to working with The Green Organic Dutchman on the development of their online store for medical and adult-use cannabis,” said Loren Padelford, VP & GM at Shopify. “Our platform will allow TGOD to rapidly scale and capitalize on emerging cannabis opportunities in a safe, secure, and reliable way.”
ABOUT THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD.
The Green Organic Dutchman Holdings Ltd. is a research & development company licensed under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) to cultivate medical cannabis. The Company carries out its principal activities producing cannabis from its facilities in Ancaster, Ont., pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.
The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a funded capacity of 170,000 kg and is building 1,382,000 sq. ft. of cultivation facilities in Ontario, Quebec and Jamaica.
The Company has developed a strategic partnership with Aurora Cannabis Inc. (TSX:ACB) whereby Aurora has invested approximately C$78.1 million for an approximate 17.5% stake in TGOD. In addition, the Company has raised approximately C$350 million dollars and has over 20,000 shareholders.
TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.
Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.